Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
α-Mangostin is a natural xanthonoid compound primarily isolated from the pericarp (rind) of the mangosteen fruit (Garcinia mangostana L.). First identified in 1855, it has gained significant attention for its diverse pharmacological properties. ## Chemical Properties α-Mangostin is a yellow crystalline solid with the chemical formula C24H26O6 and a molar mass of 410.466 g/mol[9]. It has a melting point of 182°C and a density of 1.265 g/ml[9]. The compound is a xanthone derivative with a core xanthene-9-one structure[9]. ## Pharmacological Effects α-Mangostin demonstrates a remarkable range of biological activities: **Antioxidant and Anti-inflammatory** α-Mangostin is well-established as an antioxidant and anti-inflammatory agent[1][2]. These properties form the foundation for many of its therapeutic applications. **Antimicrobial Activity** The compound exhibits antibacterial, antifungal, and antiviral properties[4]. It has also shown promising antimalarial activity against both chloroquine-resistant and chloroquine-sensitive strains of Plasmodium falciparum[4]. **Anticancer Properties** α-Mangostin has demonstrated significant anticancer effects against various cancer types: - Inhibits growth of colon cancer cells with potency similar to 5-FU[2] - Induces cell cycle arrest and apoptosis through the intrinsic mitochondrial pathway[2][7] - Suppresses tumor formation in breast cancer models and reduces lymph node metastases[2] - Inhibits pancreatic cancer cell growth both in vitro and in xenograft models[7] **Metabolic Effects** Research suggests α-mangostin has beneficial effects on metabolic conditions: - Anti-obesity properties[5] - Hepatoprotective effects[5] - Antidiabetic activity[5] **Cardiovascular Protection** α-Mangostin has shown cardioprotective effects in various models: - Reduces total cholesterol and triglycerides in mouse models[5] - Decreases atherosclerotic lesion development[5] - Protects against doxorubicin-induced cardiotoxicity[5] **Neuroprotective Potential** Computational studies suggest α-mangostin may have applications in Alzheimer's disease treatment[1]. ## Mechanism of Action α-Mangostin's diverse effects stem from multiple mechanisms: - Cell cycle regulation: Induces G0/G1 and S phase arrest by affecting expression of cyclins, cdc2, and p27[2][7] - Apoptosis induction: Activates the intrinsic mitochondrial pathway[2][7] - Modulation of inflammatory pathways: Reduces pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6[5] - Antioxidant activity: Scavenges free radicals and enhances endogenous antioxidant systems[1][5] ## Current Research and Applications Recent research has explored novel applications and delivery systems for α-mangostin, including a hydrogel film with chitosan alginate base for treating recurrent aphthous stomatitis (mouth ulcers)[10]. This formulation is currently undergoing clinical trials to evaluate its efficacy and safety. α-Mangostin continues to be investigated for its potential therapeutic applications across a wide range of conditions, from cancer and infectious diseases to metabolic disorders and inflammatory conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-Mangostin.